Peripheral neuropathy — all decisions

The Board granted a separate initial rating of 10 percent for hypertension (as a complication of diabetes) effective November 17, 2023, and denied ratings in excess of the current levels for diabetes mellitus with retinopathy and gastroparesis, neuropathy of the left foot, and entitlement to a total disability rating due to individual unemployability.

The Board granted effective dates of August 4, 2021, for several conditions and denied or remanded claims related to other issues.

The Board granted service connection for a left hand disability, to include left upper extremity neuropathy, resolving reasonable doubt in the Veteran's favor.

The Board remands the claims for further development to ensure substantial compliance with prior remand directives.

The Board granted separate ratings of 20 percent for right and left upper extremity peripheral neuropathy, but denied earlier effective dates for special monthly compensation, service connection for bilateral glaucoma, and payment of accrued benefits.

The Board denied the Veteran's claim for special monthly compensation based on loss of use of the left upper extremity, as there was no evidence that his service-connected disabilities caused effective function remaining other than that which would be equally well served by an amputation with a prosthetic appliance.

The Board denied higher ratings for the Veteran's right lower extremity neuropathy, painful scar of the right knee, and non-painful manifestations of a scar on the right knee.

The Board denied service connection for all the claimed conditions as they are not related to active service.

The Board remands the rating reduction claims for further action, including new VA examinations to reassess the Veteran's level of disability as of October 2019.

The Board granted service connection for left, right upper and lower extremity peripheral neuropathy, chemotherapy induced, but remanded claims for skin cancer, colon cancer, and entitlement to a higher level of special monthly compensation.

The Board remands the claims for service connection for bilateral foot degeneration, bilateral foot arthritis and bilateral upper extremity neuropathy as secondary to a service-connected condition due to incomplete medical opinions.

The Board remands the claims for increased ratings and special monthly compensation due to a pre-decisional duty to assist error regarding the effects of medication on the severity of peripheral neuropathy.

The Veteran's appeal seeking service connection for various conditions was withdrawn by the Veteran's authorized representative prior to the Board's decision.

The Board remands the claims for service connection of peripheral neuropathy in all four extremities due to a lack of medical nexus evidence.

The Board denied service connection for hypertension and denied increased ratings for peripheral neuropathy of the left upper extremity and a left shoulder disability. The claims for back pain were remanded.

The Board granted service connection for polyneuropathy of the bilateral upper and lower extremities, as due to herbicide exposure.

The Board denied the veteran's claims for increased ratings for diabetic peripheral neuropathy and remanded a claim for service connection for erectile dysfunction as secondary to the service-connected condition.

The Board granted an effective date of June 1, 2016, for the award of service connection for diabetic peripheral neuropathy in all extremities.

The Board denied the Veteran's request for an earlier effective date for service connection for left and right lower extremity neuropathy, sciatic nerve, as the earliest date of entitlement was January 17, 2023.

The veteran withdrew all appeals, and the Board has no jurisdiction to review them.